10x Genomics, Inc. (TXG)
Makes tools that let researchers analyze individual cells and genes in biological samples.
$46.83+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+258.0%
The outlook
TXG is trading near the top of its 52-week range with price above both key moving averages, supported by a Buy consensus from analysts. However, the average analyst price target sits roughly 11% below the current price, suggesting some caution despite the bullish technical positioning.
What’s behind the score
Analyst consensusBuy — 2.3 avg of 13 analysts
Price trendAbove its 50- & 200-day averages
52-week range93% of the way from its 52-week low to high
Price targetAvg target -11% vs current price
Analyst price target
~12-month · 13 analysts$41.54average target-11.3% vs now
Now $46.83
Low $25.00High $50.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.95B
52-wk high
$49.50
52-wk low
$11.16
50-day avg
$34.51
200-day avg
$22.64
Trailing P/E
—